Toggle Main Menu Toggle Search

Open Access padlockePrints

Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming

Lookup NU author(s): Dr Faye Cooles, Dr Jessica Tarn, Dr Dennis LendremORCiD, Najib NaamaneORCiD, Alice Lin, Benjamin Millar, Dr Nicola Maney, Dr Amy AndersonORCiD, Dr Nishanthi Thalayasingam, Julie Diboll, Dr Graham Smith, Dr Louise Reynard, Dr Arthur Pratt, Professor John IsaacsORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Cooles FAH, Tarn J, Lendrem DW, Naamane N, Lin CMA, Millar B, Maney NJ, Anderson AE, Thalayasingam N, Diboll J, Bondet V, Duffy D, Barnes MR, Smith GR, Ng S, Watson D, Henkin R, Cope AP, Reynard LN, Pratt AG, Isaacs JD

Publication type: Article

Publication status: Published

Journal: Annals of the Rheumatic Diseases

Year: 2022

Volume: 81

Issue: 9

Pages: 1214-1223

Online publication date: 09/06/2022

Acceptance date: 23/05/2022

Date deposited: 06/07/2022

ISSN (print): 0003-4967

ISSN (electronic): 1468-2060

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/annrheumdis-2022-222370

DOI: 10.1136/annrheumdis-2022-222370

PubMed id: 35680389


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
ANR and RTCure
Academy of Medical Sciences
British Society of Rheumatology
Connect Immune Research
JGW Patterson Foundation
Immune-Mediated Inflammatory Disease Biobank in the UK (IMID-Bio-UK)
MRC
The Wellcome Trust

Share